16
2024-10
"Global Longevity and Regenerative Medicine Forum" successfully held
The "Global Longevity and Regenerative Medicine Forum" hosted by San Yi Changsheng was successfully held in Beijing, attracting scientists, Nobel laureates, and representatives from international top-tier companies from universities such as Oxford and Harvard. The forum focused on the application of gene editing, cellular reprogramming, and glyco-life clock technologies in longevity medicine, providing new ideas for industry innovation and development.
09
2024-05
San Yi Changsheng signed a cooperation agreement with a renowned British life science company to jointly develop "glyco-life clock" technology, offering ultra-precise biological age assessment and disease prediction services to customers. This cooperation further consolidates San Yi Changsheng's global leadership position in the field of longevity medicine.
21
2025-03
Global cell therapy market grows rapidly
According to market research company forecasts, the cell therapy market will reach $45 billion by 2025. Induced pluripotent stem cells (iPSC) and exosome technology have become core growth drivers, with increasing demand for applications in tissue repair and anti-aging fields.
10
2024-08
Strategic cooperation with Saudi Hevolution Fund
San Yi Changsheng and Saudi Hevolution Fund officially signed a cooperation agreement to jointly promote the research and development and industrialization of longevity medicine and regenerative medicine fields. This cooperation will help San Yi Changsheng accelerate its international layout and promote the application of more breakthrough technologies.